Home » Study Shows Novartis Lung Drug Effective in “Smokers Cough” COPD
Study Shows Novartis Lung Drug Effective in “Smokers Cough” COPD
A late stage trial showed Novartis AG’s experimental medicine NVA237 worked just as well treating a lung condition linked to smoking as the standard therapy did, reinforcing prospects for the Swiss drug maker’s respiratory franchise.
Fox Business
Fox Business
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May